Tongrentang: The company's drugs are all independently produced, and there is no situation of outsourcing production to external third parties.

Tong Ren Tang issued a clarification announcement stating that the company focuses on the production and sale of medicines. The company owns products such as Angong Niuhuang Wan, Tong Ren Niuhuang Qingxin Wan, Liuwei Dihuang Wan, Jinkui Shenqi Wan, and many other classic medicines. The company produces over 400 varieties of traditional Chinese medicines annually, covering various fields such as cardiovascular, tonics, heat-clearing, gynecology, pediatrics, etc. The rich product resources provide strong support for brand development and stable operation. As of the date of this announcement, all medicines produced by the company are self-produced, and there is no outsourcing to external third parties.